Systems and methods for local modulation of wnt signaling
AssigneeOrtheus, Inc.
InventorsPaul Kostenuik, Faisal Mirza, Michael Collins
Life of this patent
Estimating the term…
Loading patent…
AssigneeOrtheus, Inc.
InventorsPaul Kostenuik, Faisal Mirza, Michael Collins
Estimating the term…
A system is provided including a promoter of Wnt signaling and an autologous body material (ABM) or its functional equivalent. The promoter of Wnt signaling can be an agent that inhibits the activity or bioavailability of DKK1 protein, e.g., an anti-DKK1 antibody (DKAB). The promoter of Wnt signaling can also be an agent that initiates, promotes, or potentiates Wnt signaling by means other than inhibition of DKK1. The ABM in some embodiments are prepared to remove DKK1 or an antagonist of Wnt signaling. A process of locally administering the system is also provided to enhance the intended or ancillary effects of the ABM. The system is useful in promoting the growth of new bone or the augmentation, reconstitution, regeneration, fusion, fixation, repair, or healing of damaged, injured or otherwise deficient bone in therapeutically or esthetically desirable locations, or for promoting hair growth or wound healing.
A composition comprising:
A method of treating, or reducing the severity of, or reducing the likelihood of developing, or accelerating the healing of a defect or deficiency in a mammal by administering a promoter of Wnt signaling directly to locally expressed autologous body materials.
A composition or a device comprising a composition, wherein the composition comprises an autologous body material (ABM), or a functional equivalent thereof, wherein DKK1 or one or more other endogenous extracellular Wnt antagonists has been removed from or reduced in the ABM, wherein the Wnt antagonists comprise DKK1, sclerostin, secreted frizzled-related proteins (sFRPs), Wnt inhibitory factor 1 (WIF-1), Wise, or a combination thereof.
(canceled)
(canceled)
Dependencies are inferred from the claim text.